Test-system in vitro for screening of therapeutic drugs with IL-17A inhibitory activity
- Autores: Ossina N.K1, Pugachev E.I1, Kolyadenko I.A2, Pryazhkina V.V1, Shakurov E.G1, Orlov E.V1, Volova L.T1
-
Afiliações:
- Samara State Medical University
- Institute of Protein Research of the RAS
- Edição: Volume 16, Nº 1 (2021)
- Páginas: 43-48
- Seção: Articles
- ##submission.dateSubmitted##: 16.01.2023
- ##submission.datePublished##: 15.03.2021
- URL: https://genescells.ru/2313-1829/article/view/121976
- DOI: https://doi.org/10.23868/202104006
- ID: 121976
Citar
Texto integral
![Acesso aberto](https://genescells.ru/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Palavras-chave
Texto integral
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
N. Ossina
Samara State Medical University
Email: nossina@gmail.com
E. Pugachev
Samara State Medical University
I. Kolyadenko
Institute of Protein Research of the RAS
V. Pryazhkina
Samara State Medical University
E. Shakurov
Samara State Medical University
E. Orlov
Samara State Medical University
L. Volova
Samara State Medical University
Bibliografia
- Beringer A., Noack M., Miossec P. IL-17 in chronic inflammation: from discovery to targeting. Trends Mol. Med. 2016; 22(3): 230-41.
- Liang Y., Sarkar M.K., Tsoi L.C. et al. Psoriasis: a mixed autoimmune and autoinflammatory disease. Curr. Opin. Immunol. 2017; 49: 1-8.
- Griffiths C.E., Barker J.N. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370(9583): 263-71.
- Ettehadi P., Greaves M.W., Wallach D. et al. Elevated tumour necrosis factor-alpha (TNF-a) biological activity in psoriatic skin lesions. Clin. Exp. Immunol. 2008; 96(1): 146-51.
- Lee E., Trepicchio W.L., Oestreicher J.L. et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 2004; 199(1): 125-30.
- Onishi R.M., Gaffen S.L. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010; 129(3): 311-21.
- Coimbra S., Figueiredo A., Castro E. et al. The roles of cells and cytokines in the pathogenesis of psoriasis. Int. J. Dermatol. 2012; 51(4): 389-98.
- Martin D.A., Towne J.E., Kricorian G. et al. The emerging role of IL-17 in the pathogenesis of psoriasis: Preclinical and clinical findings. J. Invest. Dermatol. 2013; 133(1): 17-26.
- Mease P.J., Antoni C.E. Psoriatic arthritis treatment: biological response modifiers. Ann. Rheum. Dis. 2005; 64 Suppl 2: 78-82.
- Кубанов А.А., Бакулев А.Л., Самцов А.В. и др. Нетакимаб - новый ингибитор ИЛ-17А: результаты 12 недель клинического исследования III фазы BCD-085-7/PLANETA у пациентов со среднетяжелым и тяжелым вульгарным псориазом. Вестник дерматологии и венерологии 2019; 95(2): 15-28.
- Blauvelt A., Puig L., Chimenti S. et al. Biosimilars for psoriasis: clinical studies to determine similarity. Br.J. Dermatol. 2017; 177(1): 23-33.
- Horvath P., Aulner N., Bickle M. et al. Screening out irrelevant cell-based models of disease. Nat. Rev. Drug Discov. 2016; 15(11): 751-69.
- Eglen R., Gilchrist A., Reisine T. An overview of drug screening using primary and embryonic stem cells. Comb. Chem. High Throughput Screen. 2008; 11(7): 566-72.
- Dunne A., Jowett M., Rees S. Use of primary human cells in high-throughput screens. Methods Mol. Biol. 2009; 565: 239-57.
- Podgurskaya A.D., Tsvelaya V.A., Slotvitsky M.M. et al. The Use of iPSC-Derived Cardiomyocytes and Optical Mapping for Erythromycin Arrhythmogenicity Testing. Cardiovasc. Toxicol. 2019; 19(6): 518-28.
- Liang P., Lan F., Lee A.S. et al. Drug Screening Using a Library of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Disease Specific Patterns of Cardiotoxicity. Circulation 2013; 127(16): 1-29.
- Hunsberger J.G., Efthymiou A.G., Malik N. et al. Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System. Stem Cells Dev. 2015; 24(16): 1852-64.
- Lago J.C., Puzzi M.B. The effect of aging in primary human dermal fibroblasts. PLoS One 2019; 14(7): 1-14
- Зорина А.И., Бозо И.Я., Зорин В.Л. и др. Фибробласты дермы: особенности цитогенеза, цитофизиологии и возможности клинического применения. Клеточная трансплантология и тканевая инженерия 2011; VI(2): 15-26
- Fang F., Ni K., Cai Y. et al. Biological characters of human dermal fibroblasts derived from foreskin of male infertile patients. Tissue Cell 2017; 49(1): 56-63.
- Wright J.F., Bennett F., Li B. et al. IL-17RA/IL-17RC Receptor Complex Cytokine Signals through the The Human IL-17F/IL-17A Heterodimeric. J. Immunol. Ref. 2008; 181: 2799-805.
- Debets R., Hegmans P.J.J., Deleuran M. et al. Expression of cytokines and their receptors by psoriatic fibroblasts I. Altered IL-6 synthesis. Cytokine 1996; 8(1): 70-9.
- Noack M., Beringer A., Miossec P. Additive or synergistic interactions between IL-17A or IL-17F and TNFa or IL-1 p depend on the cell type. Front. Immunol. 2019; 10: 1-12.
- Гринберг К.Н., Кухаренко В.И., Ляшко В.Н. и др. Культивирование фибробластов человека для диагностики наследственных болезней. В: Вахтин Ю.Б., Соминина А.А., редакторы. Методы культивирования клеток. Ленинград: Наука; 1987. c. 250-7.
- Gadagkar S.R., Call G.B. Computational tools for fitting the Hill equation to dose-response curves. J. Pharmacol. Toxicol. Methods 2015; 71: 68-76.
- Zaman G.J.R., de Roos J.A.D.M., Blomenrohr M. et al. Cryopre-served cells facilitate cell-based drug discovery. Drug Discov. Today 2007; 12(13-14): 521-6.
- Barygina V., Becatti M., Prignano F. et al. Fibroblasts to keratino-cytes redox signaling: The possible role of ROS in psoriatic plaque formation. Antioxidants 2019; 8(11): 1-20.
- Зорин В.Л., Зорина А.И., Петракова О.С. и др. Дермальные фибро-бласты для лечения дефектов кожи. Клеточная трансплантология и тканевая инженерия 2009; IV(4): 26-40.
- Werner S., Krieg T., Smola H. Keratinocyte-fibroblast interactions in wound healing. J. Invest. Dermatol. 2007; 127(5): 998-1008.
- Yao Z., Fanslow W.C., Seldin M.F. et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995; 3(6): 811-21.
- Benedetti G., Miossec P. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. Eur. J. Immunol. 2014; 44(2): 339-47.
- Behfar S., Hassanshahi G., Nazari A. et al. A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis. Cytokine 2018; 110: 226-31.
- Giustizieri M.L., Mascia F., Frezzolini A. et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T. cell-derived cytokines. J. Allergy Clin. Immunol. 2001; 107 Suppl 5: 871-7.
Arquivos suplementares
![](/img/style/loading.gif)